Two recent genome-wide association studies (GWAS) showed that the hepatic lipase (LIPC) and tissue inhibitor of metalloprotease 3 (TIMP3) genes may influence AMD risk [39, 40]. The gene discussed is LIPC; the disease is age-related macular degeneration.